News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

5 Tough Questions For Gilead (GILD) About The Kite Pharma (KITE) Acquisition



9/12/2017 6:42:59 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Gilead Sciences' (NASDAQ:GILD) executives answered several questions about its pending acquisition of Kite Pharma (NASDAQ:KITE) last week at the Citi biotech conference. However, that discussion didn't include the company's CEO, John Milligan.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES